Sustained Bearish Flow in KRYS
Krystal Biotech (KRYS) has been flagged for sustained short pressure, appearing on the FINRA threshold list for 77 consecutive trading days. This consistent short-volume activity indicates that the stock is under persistent bearish pressure. With a short interest of 13.7% of the float and a borrow fee of 0.3%, the stock is seeing steady shorting activity that has persisted for over two months. The stock's price performance has been volatile, and the ongoing short pressure remains a key factor for market participants.
Analyzing the Trend
The 77-day streak on the threshold list is a significant indicator of the market's ongoing skepticism toward Krystal Biotech. While the borrow fee remains low, the duration of the shorting activity suggests that traders are maintaining their positions despite the stock's price fluctuations. Analysts are watching to see if this sustained pressure will continue or if a shift in sentiment could lead to a change in the stock's trajectory.
Key Takeaways
- KRYS has been on the threshold list for 77 days.
- Short interest is 13.7% of the float.
- Borrow fee is 0.3%.
The Bottom Line
Krystal Biotech's long-standing presence on the threshold list highlights the persistent bearish sentiment that continues to weigh on the stock, making it a critical ticker for those monitoring short-selling activity.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.